JLJoseph Michael Lewis

Joseph Michael Lewis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joseph Michael Lewis has a total of 646 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Whole-genome sequencing reveals inter-household networks of gut-colonising ESBL-producing Escherichia coli in two rural Malawian districts

    by Angus M. O’FErrall, David Lally, Peter Makaula, Gladys Namacha, Joseph M. Lewis, Patrick Musicha, Richard N. Goodman, Ellie Allman, Sabrina J. Moyo, Claire S. Waddington, et al.

    Infection with extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-Ec) is a global health concern that disproportionately affects sub-Saharan Africa. Gut mucosal colonisation is thought to precede invasive infection. Understanding ESBL-Ec colonisation and transmission across communities is therefore essential. Here, we investigate the genomic epidemiology and spatial structure of 159 gut-colonising ESBL-Ec isolates from the faeces of 211 people in two rural Malawian villages using longitudinal sampling (2023–24), whole-genome sequencing and household mapping. Colonisation prevalence rose from 34.1% (95% CI: 27.8–41.0) to 54.2% (95% CI: 46.0–62.3) over one year. Isolates belonged to 33 sequence types (STs), most commonly ST38 and ST131, harbouring 46 distinct antimicrobial resistance gene types. Fifteen strains were identified in ≥3 households that were typically separated by short geographic distances ( < 400 m). Of 190 pairwise comparisons between same-strain isolates from different households sampled concurrently within villages, 88.9% differed by ≤10 single nucleotide polymorphisms, consistent with multi-household involvement in community transmission networks. Lineage-specific ST38 and ST131 network analyses linked rural isolates to urban Malawian isolates collected within the last decade. Our findings provide a transferable framework for inferring ESBL-Ec flow in community settings and highlight the need for One Health surveillance and improved sanitation infrastructure to limit transmission.

  • Open Access

    Multi-species plasmids and K. pneumoniae clonal spread contribute to bla NDM outbreak across seven UK healthcare sites

    by Caitlin Duggan, Charlotte Brookfield, David Lawrie, Victoria Owen, Timothy Neal, James Cruise, Alice J Fraser, Lewis Kelly, Fabrice E Graf, Daire Cantillon, et al.

    Objectives: The NDM carbapenemase enables Gram-negative bacteria to hydrolyse almost all β-lactam antibiotics. In 2023, a large increase of blaNDM in clinical isolates was identified in a clinical microbiology laboratory serving hospitals and GP practices in Merseyside, UK, raising concerns of a larger outbreak. Methods: We used short-read WGS and bioinformatic analyses to identify the outbreak(s) and identify potential links by combining with anonymized, routinely collected clinical metadata. A subset of isolates were long-read sequenced to analyse resistance genes and plasmids at maximum resolution. Results: The outbreak included Enterobacter hormaechei, Klebsiella pneumoniae, Escherichia coli, Citrobacter freundii, Citrobacter braakii and Enterobacter kobei and 28 STs. K. pneumoniae ST101 represented the only major clonal expansion (18/21 K. pneumoniae isolates), and combination with metadata strongly suggested a multi-site hospital-associated outbreak. We identified four variants of blaNDM, and long-read sequencing indicated blaNDM-1 spread across species was driven by an IncHI2/IncHI2A plasmid, representing 82% of blaNDM1 isolates. Conclusions: This study captured an outbreak of blaNDM-positive Enterobacterales across eight healthcare settings and highlights the complex epidemiology of spread mediated by both expansion of successful lineages (K. pneumoniae ST101) and multi-species plasmids (IncHI2/IncHI2A). It also highlights the challenge of recognizing and tracing an outbreak linked to patients moving across different healthcare systems and the importance of linked surveillance systems.

  • Open Access

    A protocol for the TRACS-Liverpool study, tracking transmission of extended-spectrum beta-lactamase producing Enterobacterales across health and social care settings in the United Kingdom

    by Sarah Gallichan, Joseph M Lewis, Sally Forrest, Maria Moore, Esther Picton-Barlow, Claudia McKeown, Christopher P. Jewell, Stacy Todd, Fabrice E Graf, Nicholas A Feasey

    Background Antimicrobial resistance (AMR) is a global public health problem. Infections caused by extended-spectrum beta-lactamase (ESBL) and carbapenemase (CP) -producing Enterobacterales (E) threaten individuals and healthcare systems worldwide. Symptomatic infection caused by Enterobacterales is typically preceded by asymptomatic colonisation and often occurs in the most vulnerable individuals, thus interrupting asymptomatic transmission is desirable. The dominant transmission routes across the healthcare continuum including hospitals, intermediate care, and long-term care facilities are not well understood. Methods Here we present a protocol describing a genomic surveillance framework developed for the Tracking Antimicrobial Resistance Across Care Settings (TRACS) Liverpool programme, which aims to identify critical ESBL-E transmission points in hospitals and care homes in Liverpool, UK. Our study integrates individual participant and healthcare facility data, validated standard operating procedures for taking and culturing stool, rectal, environmental, and staff samples, and genomic sequencing of ESBL-E, and statistical modelling approaches into a research framework for ESBL-E genomic surveillance. Discussion There is a need for improved epidemiological and laboratory approaches to studying bacterial transmission. Drug-resistant enteric bacteria are a highly tractable marker of the movement of all enteric bacteria, and interventions designed to interrupt transmission of drug-resistant bacteria are expected to have a broader healthcare impact. This protocol provides a standardised, reproducible approach for identifying ESBL-E, tracking acquisition events, and linking clinical and environmental isolates through whole-genome sequencing.

  • Open Access

    A more complete picture: capturing single nucleotide variant diversity in extended-spectrum beta-lactamase producing Escherichia coli using post-enrichment metagenomics

    by Sarah Gallichan, Tommi Mäklin, Esther Picton-Barlow, Claudia McKeown, Sally Forrest, Jukka Corander, Maria Moore, Nicholas A. Feasey, Eva Heinz, Fabrice E. Graf, et al.

    Inferring transmission relies on accurately distinguishing between isolates from the same source and those from different sources, and high-quality genomic data are frequently used to model transmission scenarios. The post-enrichment metagenome sequencing (pe-MGS) method uses a sequencing approach to analyse the diversity of a target pathogen enriched by pre-culturing and has been effectively used to analyse the transmission of nosocomial infections. However, a direct comparison of single nucleotide variant (SNV) call accuracy, cost and feasibility between single-colony whole-genome sequence (sc-WGS) data and pe-MGS for an antimicrobial resistant bacteria of clinical importance, extended-spectrum beta-lactamase producing Escherichia coli (ESBL-EC), is required for implementation in large-scale clinical studies. A spiked stool sample and rectal swabs from six study participants were pre-enriched in buffered peptone water and cultured on MacConkey agar with 1 mg l −1 cefotaxime. Seven single colonies were picked, and the remaining biomass of all colonies was collected from each plate, sequenced and analysed using the mSWEEP/mGEMS pipeline. We created a custom SNV calling workflow that allows heterozygous SNVs in a bacterial population and found that the choice of reference changed the number of measurable SNV distances between the sc-WGS and pe-MGS. Using our custom workflow with a core-gene reference captured 99% of all the SNV calls from multiple sc-WGS data in the pe-MGS data of the same culture. The plate sweep method offers a feasible, cost-effective alternative to multiple single colony picks for describing within-host ESBL-EC diversity. The workflow we developed allows for effective SNV calling from pe-MGS data that were comparable to SNV calls from multiple sc-WGS data from the same sample.


  • Open Access

    A protocol for the TRACS-Liverpool study, tracking transmission of extended-spectrum beta-lactamase producing Enterobacterales across health and social care settings in the United Kingdom

    by Sarah Gallichan, Joseph M Lewis, Sally Forrest, Maria Moore, Esther Picton-Barlow, Claudia McKeown, Christopher P. Jewell, Stacy Todd, Fabrice E Graf, Nicholas A Feasey

    Background: Antimicrobial resistance (AMR) is a global public health problem. Infections caused by extended-spectrum beta-lactamase (ESBL) and carbapenemase (CP) -producing Enterobacterales (E) threaten individuals and healthcare systems worldwide. Symptomatic infection caused by Enterobacterales is typically preceded by asymptomatic colonisation and often occurs in the most vulnerable individuals, thus interrupting asymptomatic transmission is desirable. The dominant transmission routes across the healthcare continuum including hospitals, intermediate care, and long-term care facilities are not well understood. Methods: Here we present a protocol describing a genomic surveillance framework developed for the Tracking Antimicrobial Resistance Across Care Settings (TRACS) Liverpool programme, which aims to identify critical ESBL-E transmission points in hospitals and care homes in Liverpool, UK. Our study integrates individual participant and healthcare facility data, validated standard operating procedures for taking and culturing stool, rectal, environmental, and staff samples, and genomic sequencing of ESBL-E, and statistical modelling approaches into a research framework for ESBL-E genomic surveillance. Discussion: There is a need for improved epidemiological and laboratory approaches to studying bacterial transmission. Drug-resistant enteric bacteria are a highly tractable marker of the movement of all enteric bacteria, and interventions designed to interrupt transmission of drug-resistant bacteria are expected to have a broader healthcare impact. This protocol provides a standardised, reproducible approach for identifying ESBL-E, tracking acquisition events, and linking clinical and environmental isolates through whole-genome sequencing.

  • Open Access

    Quantifying the bystander effect of antimicrobial use on the gut microbiome and resistome in Malawian adults

    by Edward Cunningham-Oakes, Vivien Price, Madalitso Mphasa, Jane Mallewa, Alistair C Darby, Nicholas A. Feasey, Joseph M. Lewis

    Antibiotic treatment for sepsis has an unintended yet crucial consequence: it exerts a bystander effect on the microbiome, changing its bacterial composition and resistome. Antimicrobial stewardship aims, in part, to minimise this effect to prevent development of subsequent drug-resistant infection, but data evaluating and quantifying these changes are largely lacking, especially in low-income settings which are disproportionately affected by antimicrobial resistance. Such data are critical to creating evidence-based stewardship protocols. Here, we address this data gap in Blantyre, Malawi. We use longitudinal sampling of human stool and metagenomic deep sequencing to describe microbiome composition and resistome pre-, during- and post-antimicrobial exposure. We develop Bayesian regression models to link these changes to individual antimicrobial agents. We find that ceftriaxone, in particular, exerts strong off-target effects, both increasing abundance of Enterobacterales, and the prevalence of macrolide and aminoglycoside resistance genes. Simulation from the fitted models allows exploration of different stewardship strategies and can inform practice in Malawi and elsewhere.


  • An evaluation of screening methods for the detection of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in environmental samples from healthcare settings

    by Esther Picton-Barlow, Claudia McKeown, Sally Forrest, Sarah Gallichan, Maria Moore, Nicholas A Feasey, Joseph M Lewis, Fabrice E Graf

    Aims: Extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) infections are increasingly problematic, leading to worse treatment outcomes and higher healthcare expenditure. This study evaluated laboratory workflows for the detection of ESBL-E in healthcare environments. We aimed to optimize workflows for organism yield, detection accuracy and practical feasibility to support future surveillance and transmission studies, which are needed to inform targeted interventions to interrupt the spread of drug-resistant organisms. Methods and Results: We sampled sinks, toilets, shower drains, shower heads, and high-touch surfaces, within six healthcare facilities in Liverpool, UK. We then assessed recovery of ESBL-producing Escherichia coli (ESBL-Ec) and Klebsiella pneumoniae (ESBL-Kp) using two swab types (foam and polyester), two pre-enrichment broths [Buffered Peptone Water (BPW) and Tryptic Soy Broth (TSB)], two incubation times (4 and 18 h) and four selective agars (CHROMagar ESBL, cefotaxime-supplemented MacConkey, Membrane Lactose Glucuronide Agar (MLGA) and Simmons Citrate Agar with Inositol). Pre-enrichment for 18 h significantly increased recovery of third-generation cephalosporin resistant Gram-negatives, compared to 4 h. The choice of selective agar impacted the number of ESBL-Ec and ESBL-Kp detected and the number of samples requiring additional species confirmation. We found CHROMagar ESBL and cefotaxime-supplemented MLGA performed best overall, demonstrating the highest yield and detection accuracy (i.e. colour of colonies matched their confirmed species) of ESBL-Ec and ESBL-Kp. Conclusions: Pre-enrichment for 18 h in BPW, followed by plating onto cefotaxime-supplemented MLGA, was the most effective screening method in our context, having a high detection efficacy, whilst maintaining a scalable and accessible cost.


  • Open Access

    A more complete picture: Capturing single nucleotide variant diversity in extended-spectrum beta-lactamase producing Escherichia coli using post-enrichment metagenomics

    by Sarah Gallichan, Tommi Mäklin, Esther Picton-Barlow, Claudia McKeown, Sally Forrest, Jukka Corander, Maria Moore, Nicholas A Feasey, Eva Heinz, Fabrice E Graf, et al.

    Inferring transmission relies on accurately distinguishing between isolates from the same source and those from different sources, and high-quality genomic data is frequently used to model transmission scenarios. The post-enrichment metagenome sequencing (pe-MGS) method uses a sequencing approach to analyse the diversity of a target pathogen enriched by pre-culturing, and has been effectively used to analyse the transmission of nosocomial infections. However, a direct comparison of single nucleotide variant (SNV) call accuracy, cost and feasibility between single colony whole genome sequence (sc-WGS) data and pe-MGS for an antimicrobial resistant bacteria of clinical importance, extended-spectrum beta-lactamase producing E. coli (ESBL-EC), is required for implementation in large-scale clinical studies. A spiked stool sample and rectal swabs from six study participants were pre-enriched in buffered peptone water and cultured on MacConkey agar with 1mg/L cefotaxime. Seven single colonies were picked, and the remaining biomass of all colonies was collected from each plate, sequenced and analysed using the mSWEEP/ mGEMS pipeline. We created a custom SNV calling workflow that allows heterozygous SNVs in a bacterial population, and found that the choice of reference changed the number of measurable SNV distances between the sc-WGS and pe-MGS. Using our custom workflow with a core-gene reference captured 99% of all the SNV calls from multiple sc-WGS data in the pe-MGS data of the same culture. The plate sweep method offers a feasible, cost-effective alternative to multiple single colony picks for describing within-host ESBL-EC diversity. The workflow we developed allows for effective SNV calling from pe-MGS data that was comparable to SNV calls from multiple sc-WGS data from the same sample. Abbreviations: AMR, antimicrobial resistance; ESBL-EC, extended-spectrum beta-lactamase producing Escherichia coli ; ST, sequence type; SNV, single nucleotide variant; BPW, buffered peptone water; sc-WGS, single-colony whole-genome sequencing; pe-MGS, post-enrichment metagenome sequencing Impact statement: For bacterial species with high within patient diversity and within-genome variation such as the opportunistic pathogen E. coli , capturing the full diversity is essential to identify transmission events. Pre-enriching the species of interest from patient samples, and then sequencing all colonies, post-enrichment metagenomics (pe-MGS) promises to be a cost-effective, efficient method capturing the full diversity. To estimate transmission events with high confidence and make it applicable for hospital transmission studies, single-nucleotide variants (SNVs) have to be identified with an equivalent resolution as would be achieved when using single-colony whole-genome sequencing on all colonies. Here we present a proof-of-concept study on a set of stool samples and rectal swabs from healthy participants, where we developed a new workflow tested against these control samples. All samples were analysed using both single-colony WGS (sc-WGS) and pe-MGS from the same plate, following pre-enrichment for the species and phenotype of interest (drug resistant Escherichia coli ). This direct comparison allowed us to assess the reconstruction of SNVs between the two approaches on clinically relevant sample types at the highest resolution. We show that by using a newly developed SNV calling workflow, a core-gene reference allowed us to identify comparable SNVs in the pe-MGS to the sc-WGS sequence data. The pe-MGS offers a cheaper and time-saving alternative to multiple sc-WGS and is thus more feasible to integrate into public health settings for routine surveillance. This would provide a robust basis to significantly improve our detection of transmission events and thus understanding of transmission routes, and allow for the targeted implementation of preventative measures. Data summary: The short-read sequence data generated in this study have been submitted to the European Nucleotide Archive (ENA, https://www.ebi.ac.uk/ena/browser/view/PRJEB101999 ), and their individual accession numbers are listed in Supplementary Table 1 . Github repository: https://github.com/joelewis101/TRACS-liverpool/tree/main/bioinformatics . All protocols developed and utilized in this study have been detailed and provided in the article and supplementary data files.


  • Open Access

    An evaluation of screening methods for the detection of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in environmental samples from healthcare settings

    by Esther Picton-Barlow, Claudia McKeown, Sally Forrest, Sarah Gallichan, Maria Moore, Nicholas A. Feasey, Joseph M. Lewis, Fabrice E. Graf

    Drug-resistant infections with extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) are increasingly problematic, especially in healthcare settings. ESBL-E infections lead to a worse treatment outcome and often require escalating antibiotic treatment to reserve antibiotics such as carbapenems. Understanding how these bacteria are transmitted within healthcare settings is complex and not well understood, but it is a requirement for effective infection prevention and control strategies. To what extent environmental ESBL-E reservoirs contribute to transmission is unclear. To accurately capture these reservoirs, laboratory processing of environmental samples needs to be optimised to reliably detect ESBL-E, which is challenging because they can be scarce and part of complex microbial communities. Here, we assessed screening methods for the detection of ESBL-producing Escherichia coli (ESBL-Ec) and Klebsiella pneumoniae (ESBL-Kp) from environmental swabs taken from healthcare settings, testing different swab types, pre-enrichment conditions and selective agars. We show that a pre-enrichment of 18 hours significantly increased the recovery of 3GC-resistant gram-negatives. The choice of selective agar impacted the number of ESBL-Ec and ESBL-Kp detected. This also affected the number of samples requiring additional species confirmation, which is costly and time-consuming. For our use case and by considering additional factors such as cost and practical aspects, Membrane Lactose Glucuronide Agar supplemented with cefotaxime performed best for the combined detection of ESBL-Ec and ESBL-Kp. Our work will guide environmental surveillance of ESBL-E by providing optimised methods for laboratory processing of environmental samples from healthcare settings.

  • Open Access

    Multi-species plasmids and K. pneumoniae clonal spread driving bla NDM outbreak across seven UK healthcare sites

    by Caitlin Duggan, Charlotte Brookfield, David Lawrie, Victoria Owen, Timothy Neal, James Cruise, Alice J Fraser, Lewis Kelly, Fabrice E Graf, Daire Cantillon, et al.

    Summary: Background: The NDM carbapenemase enables Gram-negative bacteria to hydrolyse almost all β-lactam antibiotics. In 2023, a large increase of bla NDM in clinical isolates was identified in a clinical microbiology laboratory serving hospitals and GP practices in Merseyside, UK, raising concerns of a larger outbreak. Methods: We used short read whole-genome sequencing and bioinformatic analyses to identify the outbreak(s) and identify potential links by combining with anonymised, routinely collected clinical metadata. A subset of isolates were long read sequenced to analyse resistance genes and plasmids at maximum resolution. Findings: The outbreak included Enterobacter hormaechei, Klebsiella pneumoniae, Escherichia coli, Citrobacter freundii, Citrobacter brakii, and Enterobacter kobei and 28 sequence types. K. pneumoniae ST101 represented the only major clonal expansion (18/21 K. pneumoniae isolates), and combination with metadata strongly suggested a multisite hospital-associated outbreak. We identified four variants of bla NDM , and long read sequencing indicated bla NDM-1 spread across species was driven by an IncHI2/IncHI2A plasmid, representing 82% of bla NDM1 isolates. Interpretation: This study captures an outbreak of bla NDM positive Enterobacterales across eight healthcare settings and highlights the complex epidemiology of spread mediated by both expansion of successful lineages ( K. pneumoniae ST101) and multi-species plasmids (IncHI2/IncHI2A). It also highlights the challenge recognising and tracing an outbreak linked to patients moving across different healthcare systems and the importance of linked surveillance systems. Funding: We acknowledge funding from Wellcome (217303/Z/19/Z, to EH), BBSRC (BB/V011278/1, BB/V011278/2, to EH) and an Academy of Medical Sciences Springboard award (REF: SBF009\1181, to TE). Research in context: Evidence before the study: We searched the pubmed database for similar reports using the search terms ((NDM) OR (New-Delhi metallo-β-lactamase)) AND (Enterobacterales) AND (hospitals) AND (outbreak) AND (plasmid) AND ((WGS) OR (whole genome sequencing)) (date of search 08. 03. 2026). We identified 75 studies, from 2019 to 2026, mainly focused on either country-wide surveillance data (n=25), single-species analyses (n=15), or single-hospital outbreaks (n=34). The studies, in particular high-resolution single-hospital outbreak studies, showed the complexity of tracking a plasmid-driven resistance outbreak across multiple species. Country-wide data gave important insights into the ease of spread of Enterobacteriaceae, and the importance of environmental sampling to track transmission, though limited resolution on patient movements. Added value of this study: Our study combines high-resolution patient movement data, whole-genome sequence (WGS) information to track both plasmids and species, with the insight gained via inclusion of several different hospitals, some of which based in distinct administrative systems. Our study adds an overview of the full span of complexity in tracking an outbreak in modern healthcare systems by patients moving between different hospitals and within hospitals between wards on one side, with the resolution necessary to track the Russian doll-like movement of antimicrobial resistance determinants covering movement of insertion elements within plasmids and between plasmids and chromosomes, movements of plasmids between species, and transmission of plasmid-harbouring bacteria between patients, linking back to the clinical complexity. Implications of all the available evidence: Current outbreak investigations usually focus on a specific species with a given resistance profile. Our work shows the relevance to consider mobile resistances in a different framework, i.e. that the movement of the resistance determinant itself needs to be monitored in addition to the putative clonal lineage which is the approach for typical pathogen spread. In addition, we highlight the complexity imposed by a modern clinical healthcare system, where patients need to be tracked across administrative boundaries to ensure capturing frequent transmission routes and identify high-risk points of transmission which might then spread into different hospitals and wards, losing the signal of clustered cases. Data sharing statement: All metadata used in this study is provided in the supplementary tables, and all raw sequence data is available on SRA/ENA under BioProject PRJEB89345; detailed read accessions are given in Supplementary Table 1.